Biopharmaceutical giant Amgen announced Monday it has agreed to buy popular psoriasis and psoriatic-arthritis drug Otezla from Celgene for $13.4 billion. The deal helps clear the way for Amgen ...

THOUSAND OAKS, Calif., Aug. 20, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced Otezla ® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and ...

The Company will be submitting the data for review to the Food and Drug Administration for inclusion in the Otezla prescribing information. Amgen announced positive topline results from the phase ...